The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to partner Pfizer. BioNTech is restructuring to focus on research and illnesses like cancer.
Germany: BioNTech shutting down COVID vaccine production entirely, 1,860 jobs at risk
Political Leaning Analysis
Score: 0.00 •
Center / Neutral
Left
Center
Right
Story Timeline
Tue 10:48 - Die Welt
Biontech is closing several locations – more than 1,800 jobs affected